speb/financial-data huggingface dataset:
Financial ratios for 8225.HK — annual report dated 2022-12-31
Total revenue: 1880747.1264367816
Gross profit: 825143.6781609196
Operating income: -2307040.2298850575
Net income: -2273850.574712644
Capital expenditures: 0
Operating cash flow: -740804.5977011494
Depreciation & amortization: 21695.402298850575
Net tangible assets: 20448563.218390804
Owner earnings: -2252155.1724137934
Return on net tangible assets (%): -11.013757535728843
Buffett classification: The Gruesome
Stock price: 0.03722721437740693
Shares outstanding: 995351660
Book value: 20385488.50574713
P/B ratio: 1.8176738623301298
Market cap (USD): 37054169.62772785
Debt to equity: 0
Current ratio: 4.823526209787165
Quick ratio: 4.823526209787165
Interest coverage ratio: -944.529411764706
COGS to revenue (%): 56.126814362108476
SG&A to revenue (%): 106.74560733384261
Free cash flow (dilution-adjusted): -1047844.8275862068
Buyback yield (%): 0
Retained earnings: 592959.7701149426
Receivables turnover: 0.12028596633095641
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.317071107884665
FCF margin (%): -55.714285714285715
Rule of 40 score: -55.714285714285715
Financial ratios for 8225.HK — annual report dated 2023-12-31
Total revenue: 3013361.462728551
Gross profit: 1154992.9676511954
Operating income: -8204078.76230661
Net income: -8159493.670886075
Capital expenditures: 844444.4444444444
Operating cash flow: 157665.26019690576
Depreciation & amortization: 32911.39240506329
Net tangible assets: 11929535.864978902
Owner earnings: -8971026.722925456
Return on net tangible assets (%): -75.20013204588595
Buffett classification: The Gruesome
Stock price: 0.01792573623559539
Shares outstanding: 995351660
Book value: 11840084.388185654
P/B ratio: 1.5069496748372544
Market cap (USD): 17842411.318822023
Debt to equity: 0
Current ratio: 3.190013080816698
Quick ratio: 3.190013080816698
COGS to revenue (%): 61.670945157526255
SG&A to revenue (%): 35.50058343057176
Free cash flow (dilution-adjusted): -758649.7890295358
Buyback yield (%): 0
Retained earnings: -7500562.58790436
Receivables turnover: 0.3368075205935987
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -69.29071190145278
FCF margin (%): -25.17619603267211
Revenue growth (%): 60.22151092888247
Rule of 40 score: 35.045314896210364
Financial ratios for 8225.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 9637397.260273973
Buffett classification: The Gruesome
Stock price: 0.025773195876288662
Shares outstanding: 995351660
Book value: 9550273.97260274
P/B ratio: 2.686142132944249
Market cap (USD): 25653393.298969075
Debt to equity: 0
Current ratio: 2.965016163620651
Quick ratio: 2.965016163620651
Buyback yield (%): 0
Retained earnings: -9247945.205479452
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8225.HK — annual report dated 2024-12-31
Total revenue: 3623835.616438356
Gross profit: 1379041.095890411
Operating income: -2033561.6438356165
Net income: -1988904.1095890412
Capital expenditures: 241232.87671232878
Operating cash flow: 1408767.1232876712
Depreciation & amortization: 83013.69863013699
Net tangible assets: 9637397.260273973
Owner earnings: -2147123.287671233
Return on net tangible assets (%): -22.279078361974616
Buffett classification: The Gruesome
Stock price: 0.025773195876288662
Shares outstanding: 995351660
Book value: 9550273.97260274
P/B ratio: 2.686142132944249
Market cap (USD): 25653393.298969075
Debt to equity: 0
Current ratio: 2.965016163620651
Quick ratio: 2.965016163620651
COGS to revenue (%): 61.94526347622287
SG&A to revenue (%): 38.08875784380434
Free cash flow (dilution-adjusted): 1160273.9726027397
Buyback yield (%): 0
Retained earnings: -9247945.205479452
Receivables turnover: 0.5668673795187177
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.29322833742129
FCF margin (%): 32.01784229228094
Revenue growth (%): 20.25890890490882
Rule of 40 score: 52.27675119718976
Financial ratios for 8225.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 11025383.542538354
Buffett classification: The Gruesome
Stock price: 0.020382165605095544
Shares outstanding: 995351660
Book value: 10936680.613668062
P/B ratio: 1.8549890123034818
Market cap (USD): 20287422.369426753
Debt to equity: 0
Current ratio: 3.227636616776888
Quick ratio: 3.227636616776888
Buyback yield (%): 0
Retained earnings: -8202370.990237099
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9274.T — annual report dated 2022-03-31
Total revenue: 4617390591.706278
Gross profit: 761768562.5307328
Operating income: 76913620.7179151
Net income: 61571873.463366665
Capital expenditures: 11366989.018193739
Operating cash flow: 39509916.40714637
Depreciation & amortization: 64448451.073594496
Net tangible assets: 385535158.1707917
Owner earnings: 114653335.51876743
Return on net tangible assets (%): 29.73874965457135
Capex to operating income (%): 14.778902503995736
Buffett classification: The Great
Stock price: 2.234469759055892
P/E ratio: 2.261689742107014
Shares outstanding: 62321933
Book value: 461998033.1093261
P/B ratio: 0.3014222239804517
Market cap (USD): 139256474.61440745
Debt to equity: 1.7178436485551603
Current ratio: 1.2371770762323404
Quick ratio: 0.9358795044780328
Effective tax rate (%): 18.5650807413027
Interest coverage ratio: 5.850997506234414
COGS to revenue (%): 83.50218489423408
SG&A to revenue (%): 2.771674115304199
Free cash flow (dilution-adjusted): 13432224.225536797
Buyback yield (%): 0
Retained earnings: 313268316.6693985
Inventory turnover: 9.176184903452311
Receivables turnover: 5.06817670711632
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.78560347759721
FCF margin (%): 0.29090508933040354
Rule of 40 score: 0.29090508933040354
Financial ratios for 9274.T — annual report dated 2023-03-31
Total revenue: 4952372372.372373
Gross profit: 905285285.2852854
Operating income: 153183183.1831832
Net income: 118055555.55555557
Capital expenditures: 25075075.07507508
Operating cash flow: 77387387.3873874
Depreciation & amortization: 67064564.56456457
Net tangible assets: 404144144.1441442
Owner earnings: 160045045.04504505
Return on net tangible assets (%): 39.60098082924654
Capex to operating income (%): 16.36933934522643
Buffett classification: The Great
Stock price: 4.4464714714714715
P/E ratio: 2.347307552172337
Shares outstanding: 62321933
Book value: 509046546.5465467
P/B ratio: 0.544375949530418
Market cap (USD): 277112697.13145643
Debt to equity: 1.6554678858491259
Current ratio: 1.1714331055509337
Quick ratio: 0.8240513207692345
Effective tax rate (%): 18.556113729349008
Interest coverage ratio: 12.487148102815178
COGS to revenue (%): 81.72016930036263
SG&A to revenue (%): 2.7444607492389976
Free cash flow (dilution-adjusted): 32665165.165165167
Buyback yield (%): 0
Retained earnings: 395112612.61261266
Inventory turnover: 7.4625468942508695
Receivables turnover: 5.817893177167854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.62714419590107
FCF margin (%): 0.6595862085693149
Revenue growth (%): 7.25478544673666
Rule of 40 score: 7.914371655305975
Financial ratios for 9274.T — annual report dated 2024-03-31
Total revenue: 4255381669.3079767
Gross profit: 791726096.1436872
Operating income: 104490227.15266773
Net income: 70120179.60908611
Capital expenditures: 14665874.273639726
Operating cash flow: 130857105.12414157
Depreciation & amortization: 67485472.79450607
Net tangible assets: 416930797.67564714
Owner earnings: 122939778.12995245
Return on net tangible assets (%): 29.486854608805825
Capex to operating income (%): 14.035642062689584
Buffett classification: The Great
Stock price: 4.467049656629689
P/E ratio: 3.9702575059016856
Shares outstanding: 62321933
Book value: 540795034.3370311
P/B ratio: 0.5147886939262254
Market cap (USD): 278395169.40814847
Debt to equity: 1.3219126230188771
Current ratio: 1.2242489974020734
Quick ratio: 0.890675208716927
Effective tax rate (%): 22.47207417682704
Interest coverage ratio: 7.485335856196784
COGS to revenue (%): 81.39471009488932
SG&A to revenue (%): 2.873680045311009
Free cash flow (dilution-adjusted): 103473322.76809298
Buyback yield (%): 4.914591835150954
Retained earnings: 406966455.3618595
Inventory turnover: 7.932371533133715
Receivables turnover: 5.724698190475345
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.814135463721666
FCF margin (%): 2.431587359469923
Revenue growth (%): -14.073875117967171
Rule of 40 score: -11.642287758497249
Financial ratios for 9274.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 430935705.28085166
Buffett classification: The Gruesome
Stock price: 4.404888639865527
Shares outstanding: 62321933
Book value: 635964420.7872252
P/B ratio: 0.43166121517670114
Market cap (USD): 274521174.6861605
Debt to equity: 1.0443817935530761
Current ratio: 1.1894961531244137
Quick ratio: 0.8209701632576468
Buyback yield (%): 0
Retained earnings: 449005462.949993
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9274.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 375952412.7790402
Buffett classification: The Gruesome
Stock price: 4.187408100521321
Shares outstanding: 62321933
Book value: 576219756.7170165
P/B ratio: 0.4528955559788433
Market cap (USD): 260967367.084347
Debt to equity: 1.3806690328716913
Current ratio: 1.1915314479987638
Quick ratio: 0.8181064235306238
Buyback yield (%): 0
Retained earnings: 452700173.7735597
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9274.T — annual report dated 2025-03-31
Total revenue: 4478291672.236332
Gross profit: 862959497.3933966
Operating income: 90549391.7925411
Net income: 53415318.807646036
Capital expenditures: 29374415.185135677
Operating cash flow: 74649111.08140622
Depreciation & amortization: 85088891.85937709
Net tangible assets: 375952412.7790402
Owner earnings: 109129795.48188744
Return on net tangible assets (%): 29.027555555555555
Capex to operating income (%): 32.440212577502216
Buffett classification: The Good
Stock price: 4.187408100521321
P/E ratio: 4.885627810705706
Shares outstanding: 62321933
Book value: 576219756.7170165
P/B ratio: 0.4528955559788433
Market cap (USD): 260967367.084347
Debt to equity: 1.3806690328716913
Current ratio: 1.1915314479987638
Quick ratio: 0.8181064235306238
Effective tax rate (%): 30.298273155416013
Interest coverage ratio: 4.9974179269642205
COGS to revenue (%): 80.7300139394247
SG&A to revenue (%): 3.012646968398996
Free cash flow (dilution-adjusted): 42748295.6823954
Buyback yield (%): 5.117049633870671
Retained earnings: 452700173.7735597
Inventory turnover: 7.46175492806202
Receivables turnover: 5.818256021951686
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.579842310249834
FCF margin (%): 0.9545670271415821
Revenue growth (%): 5.238308106088296
Rule of 40 score: 6.192875133229879
Financial ratios for 9274.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.925131469692776
Shares outstanding: 62321933
Market cap (USD): 306943713.4703847
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9274.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 357819650.0672948
Buffett classification: The Gruesome
Stock price: 5.20121130551817
Shares outstanding: 62321933
Book value: 568236877.5235534
P/B ratio: 0.5704479158657032
Market cap (USD): 324149542.5013459
Debt to equity: 1.0246684036001892
Current ratio: 1.1409608804716531
Quick ratio: 0.7748896710503709
Buyback yield (%): 0
Retained earnings: 462792732.166891
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9421.T — annual report dated 2021-06-30
Total revenue: 108455120.31843676
Gross profit: 19998507.327664193
Operating income: 1997222.7248055001
Net income: -465768.0477655147
Capital expenditures: 0
Operating cash flow: 1529147.8197937398
Depreciation & amortization: 3394038.3571557803
Net tangible assets: 19260385.380857605
Owner earnings: 2928270.3093902655
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.672245341053012
Shares outstanding: 5292784
Book value: 29356721.548760626
P/B ratio: 1.5635370355971419
Market cap (USD): 45900321.38519993
Debt to equity: 0.36999320820488296
Current ratio: 2.1137474357085377
Quick ratio: 1.8965340979927687
Effective tax rate (%): 161.32132775931683
Interest coverage ratio: 17.55510496183206
COGS to revenue (%): 81.56056876895597
Free cash flow (dilution-adjusted): 1529147.8197937398
Buyback yield (%): 0
Retained earnings: 19750868.463904466
Inventory turnover: 25.510095252009524
Receivables turnover: 6.825725394545286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.525448578386998
FCF margin (%): 1.4099360318848804
Rule of 40 score: 1.4099360318848804
Financial ratios for 9421.T — annual report dated 2022-06-30
Total revenue: 77989677.13595432
Gross profit: 7107518.852038949
Operating income: -6364096.932425506
Net income: -9016948.532103375
Capital expenditures: 0
Operating cash flow: -5022044.073504649
Depreciation & amortization: 1583988.5789589281
Net tangible assets: 9379478.731971594
Owner earnings: -7432959.953144446
Return on net tangible assets (%): -79.2470473631749
Buffett classification: The Gruesome
Stock price: 4.875905996046563
Shares outstanding: 5292784
Book value: 13855135.80789223
P/B ratio: 1.862639067505851
Market cap (USD): 25807117.241379313
Debt to equity: 0.858961263912352
Current ratio: 1.7596397121972838
Quick ratio: 1.6441175502113607
Interest coverage ratio: -70.21016073015103
COGS to revenue (%): 90.88658084732285
Free cash flow (dilution-adjusted): -5022044.073504649
Buyback yield (%): 0
Retained earnings: 6714547.185006223
Inventory turnover: 45.24054353362273
Receivables turnover: 6.3445138166330866
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.121743532533706
FCF margin (%): -6.439370257617616
Revenue growth (%): -28.090368710146997
Rule of 40 score: -34.529738967764615
Financial ratios for 9421.T — annual report dated 2023-06-30
Total revenue: 69978090.89653267
Gross profit: 10313385.826771654
Operating income: -1653108.164111065
Net income: -3241027.7662660587
Capital expenditures: 0
Operating cash flow: 2347451.305428927
Depreciation & amortization: 870479.3479762397
Net tangible assets: 6061237.74001934
Owner earnings: -2370548.418289819
Return on net tangible assets (%): -39.10997258263384
Buffett classification: The Gruesome
Stock price: 4.4619422572178475
Shares outstanding: 5292784
Book value: 9558765.022793204
P/B ratio: 2.4706221495782263
Market cap (USD): 23616096.587926507
Debt to equity: 1.170333068866797
Current ratio: 1.3810687869239675
Quick ratio: 1.2948100417432609
Interest coverage ratio: -17.2918864243913
COGS to revenue (%): 85.26196899390688
Free cash flow (dilution-adjusted): 2347451.305428927
Buyback yield (%): 0
Retained earnings: 2910899.2954828013
Inventory turnover: 46.41702623844042
Receivables turnover: 7.794311493104199
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.698744033609747
FCF margin (%): 3.3545517966470277
Revenue growth (%): -10.272623933877266
Rule of 40 score: -6.918072137230238
Financial ratios for 9421.T — annual report dated 2024-06-30
Total revenue: 60353002.67595992
Gross profit: 10980036.094343144
Operating income: 639261.9329143071
Net income: 1778436.7415520567
Capital expenditures: 0
Operating cash flow: 4114269.7118675713
Depreciation & amortization: 696620.8227020972
Net tangible assets: 7555566.618955754
Owner earnings: 2475057.564254154
Return on net tangible assets (%): 32.75806685423983
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.696558591075985
P/E ratio: 11.001283154347622
Shares outstanding: 5292784
Book value: 10390783.496172756
P/B ratio: 1.882926939351199
Market cap (USD): 19565086.165909518
Debt to equity: 0.6590071839467687
Current ratio: 1.8272916722395673
Quick ratio: 1.7089175325361858
Effective tax rate (%): -0.479585952772738
Interest coverage ratio: 4.91027724665392
COGS to revenue (%): 81.80696596578885
Free cash flow (dilution-adjusted): 4114269.7118675713
Buyback yield (%): 0
Retained earnings: 4333157.010392682
Inventory turnover: 42.68688091510231
Receivables turnover: 12.055865505101737
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.327199521797757
FCF margin (%): 6.81700914527387
Revenue growth (%): -13.754430990128167
Rule of 40 score: -6.937421844854297
Financial ratios for 9421.T — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.920124152783936
Shares outstanding: 5292784
Market cap (USD): 15455586.393868372
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9421.T — annual report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.566841959590368
Shares outstanding: 5292784
Market cap (USD): 24171308.05424855
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9421.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.205921938088829
Shares outstanding: 5292784
Market cap (USD): 22261036.339165542
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9688.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.487179487179487
Shares outstanding: 1129225460
Market cap (USD): 7325488240.51282
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9688.HK — annual report dated 2022-12-31
Total revenue: 33962212.64367816
Gross profit: 20261781.609195404
Operating income: -56449137.93103448
Net income: -63690517.24137931
Capital expenditures: 3532327.5862068967
Operating cash flow: -52822126.43678161
Depreciation & amortization: 1182040.2298850575
Net tangible assets: 149021839.08045977
Owner earnings: -66040804.597701155
Return on net tangible assets (%): -44.31619218042561
Buffett classification: The Gruesome
Stock price: 3.1578947368421053
Shares outstanding: 1129225460
Book value: 150229166.66666666
P/B ratio: 23.736902866235067
Market cap (USD): 3565975136.8421054
Debt to equity: 0.019503727542691005
Current ratio: 8.040045193861644
Quick ratio: 7.813925716165388
COGS to revenue (%): 31.313537273084947
R&D to revenue (%): 121.16576485867914
SG&A to revenue (%): 109.55845957940072
Free cash flow (dilution-adjusted): -65219540.22988506
Buyback yield (%): 0
Retained earnings: -267436781.6091954
Inventory turnover: 2.3407861863951167
Receivables turnover: 4.866628234955014
Capitalized R&D asset: 41150574.712643676
ROCI (R&D-adjusted, %): -14.776208879841993
FCF margin (%): -192.03560414084282
Rule of 40 score: -192.03560414084282
Financial ratios for 9688.HK — annual report dated 2023-12-31
Total revenue: 42040928.270042196
Gross profit: 24036990.15471167
Operating income: -52621659.63431786
Net income: -47063291.1392405
Capital expenditures: 449648.38255977497
Operating cash flow: -27873136.427566808
Depreciation & amortization: 1269901.5471167369
Net tangible assets: 109656821.37834036
Owner earnings: -46243037.974683546
Return on net tangible assets (%): -42.17068978785625
Buffett classification: The Gruesome
Stock price: 2.7528809218950063
Shares outstanding: 1129225460
Book value: 111971589.31082982
P/B ratio: 27.76260696561756
Market cap (USD): 3108623225.352113
Debt to equity: 0.01903109840501031
Current ratio: 4.627073822925438
Quick ratio: 4.406324021135881
COGS to revenue (%): 32.055026412544194
R&D to revenue (%): 88.94553897313916
SG&A to revenue (%): 94.21132042648145
Free cash flow (dilution-adjusted): -40267651.19549929
Buyback yield (%): 0
Retained earnings: -308857946.5541491
Inventory turnover: 2.1374617975773527
Receivables turnover: 4.575191710161787
Capitalized R&D asset: 64964415.29657112
ROCI (R&D-adjusted, %): -22.733059000623047
Rosenberg metric: 0.0917413322141603
FCF margin (%): -95.78202207345998
Revenue growth (%): 23.787365420279343
Rule of 40 score: -71.99465665318064
Financial ratios for 9688.HK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.447876447876448
Shares outstanding: 1129225460
Market cap (USD): 2764204407.8764477
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9688.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.7061855670103094
Shares outstanding: 1129225460
Market cap (USD): 3055893641.7525773
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9688.HK — annual report dated 2024-12-31
Total revenue: 58250547.94520548
Gross profit: 34401095.89041096
Operating income: -37526986.30136986
Net income: -35219589.04109589
Capital expenditures: 770958.904109589
Operating cash flow: -29434109.589041095
Depreciation & amortization: 1624109.589041096
Net tangible assets: 107118356.16438356
Owner earnings: -34366438.35616438
Return on net tangible assets (%): -32.08267899801014
Buffett classification: The Gruesome
Stock price: 2.7061855670103094
Shares outstanding: 1129225460
Book value: 115191506.84931508
P/B ratio: 26.528810372713234
Market cap (USD): 3055893641.7525773
Debt to equity: 0.18250846119267733
Current ratio: 3.508793025702691
Quick ratio: 3.37560332013962
Interest coverage ratio: -121.53815439219164
COGS to revenue (%): 34.77185234309042
R&D to revenue (%): 55.14769688802974
SG&A to revenue (%): 70.25414541341254
Free cash flow (dilution-adjusted): -47540000
Buyback yield (%): 0
Retained earnings: -336038767.1232877
Inventory turnover: 3.708087774294671
Receivables turnover: 4.75589133328114
Capitalized R&D asset: 70757190.53180768
ROCI (R&D-adjusted, %): -22.006984178255827
Rosenberg metric: 0.27716307258046075
FCF margin (%): -81.61296618998234
Revenue growth (%): 38.556759667730844
Rule of 40 score: -43.0562065222515
Financial ratios for 9688.HK — quarterly report dated 2025-03-31
Total revenue: 15588154.269972453
Gross profit: 9344352.61707989
Operating income: -7754132.231404959
Net income: -6671900.826446281
Capital expenditures: 211294.76584022038
Operating cash flow: -8498484.84848485
Depreciation & amortization: 476308.5399449036
Net tangible assets: 103536225.89531681
Owner earnings: -6406887.052341597
Return on net tangible assets (%): -6.188063160443437
Buffett classification: The Gruesome
Stock price: 3.663239074550128
Shares outstanding: 1129225460
Book value: 111673966.94214877
P/B ratio: 37.04196190318703
Market cap (USD): 4136622829.048843
Debt to equity: 0.23718444458423216
Current ratio: 3.257802362049611
Quick ratio: 3.0919085573486504
Interest coverage ratio: -47.42628475147431
COGS to revenue (%): 34.149509587346465
R&D to revenue (%): 53.661747813024654
SG&A to revenue (%): 56.041353715649024
Free cash flow (dilution-adjusted): -11207438.016528927
Buyback yield (%): 0
Retained earnings: -344562121.21212125
Inventory turnover: 0.728446488483432
Receivables turnover: 1.290819294423597
Capitalized R&D asset: 8364876.033057852
ROCI (R&D-adjusted, %): -1.729173138259473
FCF margin (%): -71.89714588671909
Rule of 40 score: -71.89714588671909
Financial ratios for 9688.HK — quarterly report dated 2025-06-30
Total revenue: 16376847.977684798
Gross profit: 9310599.721059972
Operating income: -7119246.8619246865
Net income: -5680195.258019526
Capital expenditures: 395676.429567643
Operating cash flow: -4326917.712691771
Depreciation & amortization: 520920.5020920502
Net tangible assets: 102141701.53417015
Owner earnings: -5554951.185495118
Return on net tangible assets (%): -5.438475277051051
Buffett classification: The Gruesome
Stock price: 3.4968152866242037
Shares outstanding: 1129225460
Book value: 110423291.49232915
P/B ratio: 35.759601051627364
Market cap (USD): 3948692850.5732484
Debt to equity: 0.24174755442161835
Current ratio: 3.1193329733545303
Quick ratio: 2.933209854570575
Interest coverage ratio: -40.44770206022187
COGS to revenue (%): 36.80741258026605
R&D to revenue (%): 43.10435863807464
SG&A to revenue (%): 60.49803273662516
Free cash flow (dilution-adjusted): -7276150.6276150625
Buyback yield (%): 0
Retained earnings: -354567364.0167364
Inventory turnover: 0.700486223662885
Receivables turnover: 1.1819975438384571
Capitalized R&D asset: 12663602.22806229
ROCI (R&D-adjusted, %): -4.038820305271754
Rosenberg metric: -0.004035074266077117
FCF margin (%): -44.42949362129754
Revenue growth (%): 5.059570838554054
Rule of 40 score: -39.36992278274349
Financial ratios for 9688.HK — quarterly report dated 2025-09-30
Total revenue: 17954634.831460673
Gross profit: 9720786.516853932
Operating income: -6737078.651685393
Net income: -5050983.146067415
Capital expenditures: 416853.93258426967
Operating cash flow: -4500561.797752809
Depreciation & amortization: 547893.2584269663
Net tangible assets: 98569522.4719101
Owner earnings: -4919943.820224719
Return on net tangible assets (%): -4.991343872672998
Buffett classification: The Gruesome
Stock price: 3.429305912596401
Shares outstanding: 1129225460
Book value: 106733848.31460673
P/B ratio: 36.2814571739042
Market cap (USD): 3872459546.6323905
Debt to equity: 0.2886551000401345
Current ratio: 2.8711423163196383
Quick ratio: 2.684536466454864
Interest coverage ratio: -34.26285714285714
COGS to revenue (%): 36.67404585526882
R&D to revenue (%): 37.491493073210414
SG&A to revenue (%): 54.84014800096998
Free cash flow (dilution-adjusted): -7451264.044943821
Buyback yield (%): 0
Retained earnings: -362108286.5168539
Inventory turnover: 0.6983391673493707
Receivables turnover: 1.2174372648921479
Capitalized R&D asset: 14221490.406628458
ROCI (R&D-adjusted, %): -5.844145174688178
Rosenberg metric: 0.058107229735699456
FCF margin (%): -41.50050454876132
Revenue growth (%): 9.634252304996533
Rule of 40 score: -31.866252243764787
Financial ratios for 9688.HK — quarterly report dated 2025-12-31
Total revenue: 20111000
Gross profit: 9323714.285714285
Operating income: -9752000
Net income: -7201285.714285715
Capital expenditures: 96428.57142857143
Operating cash flow: -3717428.5714285714
Depreciation & amortization: 559428.5714285715
Net tangible assets: 90929000
Owner earnings: -6738285.714285715
Return on net tangible assets (%): -7.410491388100292
Buffett classification: The Gruesome
Stock price: 1.749357326478149
Shares outstanding: 1129225460
Book value: 102214285.7142857
P/B ratio: 19.32624992575347
Market cap (USD): 1975418831.696658
Debt to equity: 0.3134297693920336
Current ratio: 2.449229394039878
Quick ratio: 2.2696255820994504
Interest coverage ratio: -50.15723732549596
COGS to revenue (%): 44.27640878836742
R&D to revenue (%): 43.78058915874042
SG&A to revenue (%): 51.882764940295644
Free cash flow (dilution-adjusted): -6174571.428571429
Buyback yield (%): 0
Retained earnings: -375517142.85714287
Inventory turnover: 0.8339153120610073
Receivables turnover: 1.190150906708374
Capitalized R&D asset: 15644307.581751142
ROCI (R&D-adjusted, %): -6.855892391031516
Rosenberg metric: -0.058987528912416244
FCF margin (%): -30.702458498192183
Revenue growth (%): 12.010075330303438
Rule of 40 score: -18.692383167888742
Financial ratios for 9688.HK — annual report dated 2025-12-31
Total revenue: 71315142.85714285
Gross profit: 38439285.71428572
Operating income: -31938857.14285714
Net income: -25076714.285714287
Capital expenditures: 1144857.142857143
Operating cash flow: -21541285.714285713
Depreciation & amortization: 2144285.714285714
Net tangible assets: 90929000
Owner earnings: -24077285.714285716
Return on net tangible assets (%): -26.479215337555363
Buffett classification: The Gruesome
Stock price: 1.749357326478149
Shares outstanding: 1129225460
Book value: 102214285.7142857
P/B ratio: 19.32624992575347
Market cap (USD): 1975418831.696658
Debt to equity: 0.3134297693920336
Current ratio: 2.449229394039878
Quick ratio: 2.2696255820994504
Interest coverage ratio: -42.920330197734685
COGS to revenue (%): 38.27698385035436
R&D to revenue (%): 44.25107070027204
SG&A to revenue (%): 55.609307580437736
Free cash flow (dilution-adjusted): -32830142.85714286
Buyback yield (%): 0
Retained earnings: -375517142.85714287
Inventory turnover: 2.5564385577630606
Receivables turnover: 4.2203660650124695
Capitalized R&D asset: 65420549.127630934
ROCI (R&D-adjusted, %): -19.64399185022156
Rosenberg metric: 0.12570696326836953
FCF margin (%): -46.035304062851814
Revenue growth (%): 22.42827814122339
Rule of 40 score: -23.607025921628424
Financial ratios for ABBOTINDIA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 220.8557299221944
Shares outstanding: 21249302
Market cap (USD): 4693030103.547145
Buyback yield (%): 0
Retained earnings: 284636687.3269155
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABBOTINDIA.NS — annual report dated 2023-03-31
Total revenue: 651246041.4129112
Gross profit: 287790499.3909866
Operating income: 139740560.29232645
Net income: 115640682.0950061
Capital expenditures: 4096224.116930573
Operating cash flow: 108817295.98051158
Depreciation & amortization: 8522533.495736906
Net tangible assets: 387456760.0487211
Owner earnings: 120066991.47381243
Return on net tangible assets (%): 30.98848796926772
Capex to operating income (%): 2.9313064928046577
Buffett classification: The Great
Stock price: 257.7017052375153
P/E ratio: 47.3534163003992
Shares outstanding: 21249302
Book value: 388372716.1997564
P/B ratio: 14.099809621256755
Market cap (USD): 5475981360.506944
Debt to equity: 0.0354927333513144
Current ratio: 2.5083414868741816
Quick ratio: 1.9703321669624057
Effective tax rate (%): 25.467491482313044
Interest coverage ratio: 71.74921826141339
COGS to revenue (%): 55.809251636046696
SG&A to revenue (%): 6.539324035438483
Free cash flow (dilution-adjusted): 103174177.83191231
Buyback yield (%): 0
Retained earnings: 295799025.57856274
Inventory turnover: 4.598859520690453
Receivables turnover: 16.77142409033877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.25208016742848
FCF margin (%): 15.842580418311753
Rule of 40 score: 15.842580418311753
Financial ratios for ABBOTINDIA.NS — annual report dated 2024-03-31
Total revenue: 701185993.5244035
Gross profit: 313567574.04964626
Operating income: 168550185.87360594
Net income: 144048447.05600193
Capital expenditures: 5771675.260822641
Operating cash flow: 145438301.95467082
Depreciation & amortization: 8534596.47439741
Net tangible assets: 442766518.76723826
Owner earnings: 146811368.2695767
Return on net tangible assets (%): 33.15773936076572
Capex to operating income (%): 3.424306672168704
Buffett classification: The Great
Stock price: 316.3077015355086
P/E ratio: 46.66012034299008
Shares outstanding: 21249302
Book value: 443565175.6805372
P/B ratio: 15.152943114936253
Market cap (USD): 6721317874.853887
Debt to equity: 0.022501344998094024
Current ratio: 2.4173617731172548
Quick ratio: 1.955925285986654
Effective tax rate (%): 25.747488796167517
Interest coverage ratio: 112.89477911646586
COGS to revenue (%): 55.280399644957654
SG&A to revenue (%): 5.766188545267044
Free cash flow (dilution-adjusted): 137955390.3345725
Buyback yield (%): 0
Retained earnings: 338051325.09893274
Inventory turnover: 5.217001839956099
Receivables turnover: 18.323430791889947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.50023242104826
FCF margin (%): 19.674578729269957
Revenue growth (%): 7.668369392794316
Rule of 40 score: 27.34294812206427
Financial ratios for ABBOTINDIA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 419633301.48112756
Buffett classification: The Gruesome
Stock price: 343.5843287147635
Shares outstanding: 21249302
Book value: 420581700.9077879
P/B ratio: 17.35911749743007
Market cap (USD): 7300927163.327282
Debt to equity: 0.017182081786709304
Current ratio: 2.24652245582579
Quick ratio: 1.7121374244483645
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABBOTINDIA.NS — quarterly report dated 2025-03-31
Total revenue: 187583586.6261398
Gross profit: 87518120.17769463
Operating income: 48002104.27870002
Net income: 42908580.780921206
Capital expenditures: 0
Depreciation & amortization: 2096095.3939677342
Net tangible assets: 494118541.0334346
Owner earnings: 45004676.17488894
Return on net tangible assets (%): 9.108072747232468
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 353.5834986579531
P/E ratio: 43.77564119144781
Shares outstanding: 21249302
Book value: 494873743.27799857
P/B ratio: 15.182463501561724
Market cap (USD): 7513402545.19944
Debt to equity: 0.046459492340219455
Current ratio: 3.3850368464812854
Quick ratio: 2.7582273893361946
Effective tax rate (%): 23.962627664643364
Interest coverage ratio: 104.74744897959184
COGS to revenue (%): 53.34446805726074
Buyback yield (%): 0
Retained earnings: 376523263.97007245
Inventory turnover: 0.9704321799464878
Receivables turnover: 4.220051021749994
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.104192349649233
Rule of 40 score: 0
Financial ratios for ABBOTINDIA.NS — annual report dated 2025-03-31
Total revenue: 749002805.7049333
Gross profit: 338546878.6532616
Operating income: 192266775.77741405
Net income: 165354220.24783725
Capital expenditures: 6088379.705400982
Operating cash flow: 118288519.99064764
Depreciation & amortization: 8393733.925648818
Net tangible assets: 494118541.0334346
Owner earnings: 167659574.46808508
Return on net tangible assets (%): 33.93104296742841
Capex to operating income (%): 3.1666311981272615
Buffett classification: The Great
Stock price: 353.5834986579531
P/E ratio: 45.43822669864824
Shares outstanding: 21249302
Book value: 494873743.27799857
P/B ratio: 15.182463501561724
Market cap (USD): 7513402545.19944
Debt to equity: 0.046459492340219455
Current ratio: 3.3850368464812854
Quick ratio: 2.7582273893361946
Effective tax rate (%): 25.04093908158669
Interest coverage ratio: 143.88888888888889
COGS to revenue (%): 54.800319027559055
SG&A to revenue (%): 5.328571852217195
Free cash flow (dilution-adjusted): 110700257.18961887
Buyback yield (%): 0
Retained earnings: 376523263.97007245
Inventory turnover: 3.9805904494127247
Receivables turnover: 16.850248533782185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.46577031209813
FCF margin (%): 14.779685249033472
Revenue growth (%): 6.819419187223918
Rule of 40 score: 21.59910443625739
Financial ratios for ABBOTINDIA.NS — quarterly report dated 2025-06-30
Total revenue: 203410952.49239412
Gross profit: 93169904.04867776
Operating income: 49860753.568921134
Net income: 42810671.659255795
Capital expenditures: 0
Depreciation & amortization: 2279428.9726187694
Owner earnings: 45090100.63187456
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 411.6549262813012
P/E ratio: 51.08177184162384
Shares outstanding: 21249302
Market cap (USD): 8747379848.339106
Effective tax rate (%): 25.80861030559893
Interest coverage ratio: 73.2147766323024
COGS to revenue (%): 54.196220553973596
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 8.43750039698238
Rule of 40 score: 8.43750039698238
Financial ratios for ABBOTINDIA.NS — quarterly report dated 2025-09-30
Total revenue: 198100338.21871477
Gross profit: 92480270.57497181
Operating income: 54512965.05073281
Net income: 46817361.894024804
Capital expenditures: 0
Depreciation & amortization: 2101465.614430665
Net tangible assets: 451623449.83089066
Owner earnings: 48918827.50845547
Return on net tangible assets (%): 10.831773134626427
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 330.2142051860203
P/E ratio: 52.94251257236909
Shares outstanding: 21249302
Book value: 452188275.0845547
P/B ratio: 15.517477469701392
Market cap (USD): 7016821370.687712
Debt to equity: 0.04548843030633946
Current ratio: 2.7547726115730526
Quick ratio: 2.0916553538096045
Effective tax rate (%): 23.93347132416244
Interest coverage ratio: 64.04370860927153
COGS to revenue (%): 53.31644993313035
Buyback yield (%): 0
Inventory turnover: 0.9989230802038683
Receivables turnover: 3.46366127220043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.297060376529739
Revenue growth (%): -2.610780888938573
Rule of 40 score: -2.610780888938573
Financial ratios for ABBOTINDIA.NS — quarterly report dated 2025-12-31
Total revenue: 192050796.47989306
Gross profit: 90813189.26144592
Operating income: 49537707.47465746
Net income: 41880360.922357135
Capital expenditures: 0
Depreciation & amortization: 2090898.9640191603
Owner earnings: 43971259.88637629
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 323.3262782666815
P/E ratio: 39.390992312065045
Shares outstanding: 21249302
Market cap (USD): 6870457731.424752
Effective tax rate (%): 26.134622185547567
Interest coverage ratio: 81.14963503649635
COGS to revenue (%): 52.71397415373193
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.053776582724788
Rule of 40 score: -3.053776582724788
Financial ratios for ABFRL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.983911380720032
Shares outstanding: 1216777241
Market cap (USD): 4847532698.221021
Buyback yield (%): 0
Retained earnings: -166871950.4154029
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABFRL.NS — annual report dated 2023-03-31
Total revenue: 1505830694.2752743
Gross profit: 825537149.817296
Operating income: 41170523.75152253
Net income: -4384896.46772229
Capital expenditures: 81702801.46163216
Operating cash flow: 77490864.79902558
Depreciation & amortization: 149447015.83434838
Net tangible assets: -53336175.39585871
Owner earnings: 63359317.90499392
Capex to operating income (%): 198.44975000739623
Buffett classification: The Gruesome
Stock price: 2.610840438489647
Shares outstanding: 1216777241
Book value: 407551766.138855
P/B ratio: 7.794865559125824
Market cap (USD): 3176811225.4366627
Debt to equity: 1.9642408846383748
Current ratio: 1.0023682006847372
Quick ratio: 0.41320069172709495
Interest coverage ratio: 0.716882290562036
COGS to revenue (%): 45.177292974851305
SG&A to revenue (%): 8.631410020488769
Free cash flow (dilution-adjusted): -9306942.75274056
Buyback yield (%): 0.045664341120512285
Retained earnings: -178990255.7856273
Inventory turnover: 1.3252744175893014
Receivables turnover: 13.946651775641895
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4183271525469316
FCF margin (%): -0.6180603694773138
Rule of 40 score: -0.6180603694773138
Financial ratios for ABFRL.NS — annual report dated 2024-03-31
Total revenue: 765717711.95587
Gross profit: 392413958.5082144
Operating income: -73906943.27857058
Net income: -75311188.3918935
Capital expenditures: 88875164.88787624
Operating cash flow: 160858616.1410241
Depreciation & amortization: 198492625.0149898
Net tangible assets: -264793140.66434824
Owner earnings: 34306271.735220045
Buffett classification: The Gruesome
Stock price: 2.4658109404990403
Shares outstanding: 1216777241
Book value: 564769156.9732583
P/B ratio: 5.312511485378623
Market cap (USD): 3000342633.0080376
Debt to equity: 2.0065971492331633
Current ratio: 1.007777516998505
Quick ratio: 0.4868862068447236
Interest coverage ratio: -1.1257626127936289
COGS to revenue (%): 48.752137715885816
SG&A to revenue (%): 10.916289238440672
Free cash flow (dilution-adjusted): 68235999.52032618
Buyback yield (%): 0
Retained earnings: -266807770.71591318
Inventory turnover: 0.6909534019630039
Receivables turnover: 4.977720263802055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.466564721741085
FCF margin (%): 8.911377973226088
Revenue growth (%): -49.14981379600617
Rule of 40 score: -40.23843582278008
Financial ratios for ABFRL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -295647396.0821787
Buffett classification: The Gruesome
Stock price: 4.171046344959389
Shares outstanding: 1216777241
Book value: 489933110.3678932
P/B ratio: 10.359035052543806
Market cap (USD): 5075234263.702819
Debt to equity: 2.4378748427488945
Current ratio: 1.0063455678863948
Quick ratio: 0.48332075401373475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABFRL.NS — quarterly report dated 2024-12-31
Total revenue: 256500757.6640634
Gross profit: 145746590.51171464
Operating income: 615456.3468935773
Net income: -4937638.419396199
Capital expenditures: 0
Depreciation & amortization: 34547150.01748455
Owner earnings: 29609511.598088354
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.2632008392586545
Shares outstanding: 1216777241
Market cap (USD): 3970588514.02203
Interest coverage ratio: 0.03503882142146127
COGS to revenue (%): 43.17888499082036
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABFRL.NS — quarterly report dated 2025-03-31
Total revenue: 201014729.95090014
Gross profit: 127010755.20224455
Operating income: -12820902.501753565
Net income: -1191255.5529576805
Capital expenditures: 0
Depreciation & amortization: 36773439.326630816
Net tangible assets: 143335281.73953706
Owner earnings: 35582183.77367313
Buffett classification: The Gruesome
Stock price: 2.9906640214727505
Shares outstanding: 1216777241
Book value: 796503390.2267945
P/B ratio: 4.568683525338701
Market cap (USD): 3638971916.805578
Debt to equity: 0.7362434301196632
Current ratio: 1.5466604061509568
Quick ratio: 0.9203391906582219
Interest coverage ratio: -0.7649438515728535
COGS to revenue (%): 36.815199944169166
Buyback yield (%): 0
Retained earnings: -493703530.5120411
Inventory turnover: 0.25791744588268367
Receivables turnover: 4.604434447300771
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8621340234388511
Revenue growth (%): -21.63191571770434
Rule of 40 score: -21.63191571770434
Financial ratios for ABFRL.NS — annual report dated 2025-03-31
Total revenue: 859800093.5234977
Gross profit: 488386719.66331536
Operating income: -57280804.30208089
Net income: -43935001.16904372
Capital expenditures: 69286883.32943651
Operating cash flow: 196554828.1505728
Depreciation & amortization: 211295300.4442366
Net tangible assets: 143335281.73953706
Owner earnings: 98073415.94575638
Buffett classification: The Gruesome
Stock price: 2.9906640214727505
Shares outstanding: 1216777241
Book value: 796503390.2267945
P/B ratio: 4.568683525338701
Market cap (USD): 3638971916.805578
Debt to equity: 0.7362434301196632
Current ratio: 1.5466604061509568
Quick ratio: 0.9203391906582219
Interest coverage ratio: -0.863568268739315
COGS to revenue (%): 43.19764287744078
SG&A to revenue (%): 11.710015187505183
Free cash flow (dilution-adjusted): 116415711.94762683
Buyback yield (%): 0
Retained earnings: -493703530.5120411
Inventory turnover: 1.2944438332946273
Receivables turnover: 19.69454263067695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.851813885333895
FCF margin (%): 13.539858023340082
Revenue growth (%): 12.286823211561003
Rule of 40 score: 25.826681234901088
Financial ratios for ABFRL.NS — quarterly report dated 2025-06-30
Total revenue: 214306108.12075827
Gross profit: 122892581.32459632
Operating income: -23862625.7898432
Net income: -27349637.257196352
Capital expenditures: 0
Depreciation & amortization: 36929557.687807165
Owner earnings: 9579920.430610813
Buffett classification: The Gruesome
Stock price: 0.877603557219752
Shares outstanding: 1216777241
Market cap (USD): 1067848035.0456355
Interest coverage ratio: -1.7989590684544812
COGS to revenue (%): 42.65558625359003
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 6.612141395361763
Rule of 40 score: 6.612141395361763
Financial ratios for ABFRL.NS — quarterly report dated 2025-12-31
Total revenue: 264415729.08544058
Gross profit: 155497382.19895288
Operating income: -4543834.243065612
Net income: -15294641.862537596
Capital expenditures: 0
Depreciation & amortization: 38933942.29698118
Owner earnings: 23639300.43444358
Buffett classification: The Gruesome
Stock price: 0.8552968697783224
Shares outstanding: 1216777241
Market cap (USD): 1040705765.4448035
Interest coverage ratio: -0.30794202023252304
COGS to revenue (%): 41.192083112155906
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 23.38226446464433
Rule of 40 score: 23.38226446464433
Financial ratios for ABUS — annual report dated 2021-12-31
Capital expenditures: 809000
Buffett classification: The Gruesome
Stock price: 3.89
Shares outstanding: 197537710
Market cap (USD): 768421691.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABUS — annual report dated 2022-12-31
Total revenue: 39019000
Operating income: -63223000
Net income: -69456000
Capital expenditures: 512000
Operating cash flow: -35356000
Depreciation & amortization: 1427000
Net tangible assets: 136852000
Owner earnings: -68541000
Return on net tangible assets (%): -50.084032385350596
Buffett classification: The Gruesome
Stock price: 2.33
Shares outstanding: 197537710
Book value: 136852000
P/B ratio: 3.3632162065589104
Market cap (USD): 460262864.3
Debt to equity: 0.01598076754450063
Current ratio: 4.59990260827221
Quick ratio: 4.59990260827221
Interest coverage ratio: -36.6297798377752
COGS to revenue (%): 0
R&D to revenue (%): 216.32537994310462
SG&A to revenue (%): 45.70593813270458
Free cash flow (dilution-adjusted): -43050000
Buyback yield (%): 0
Retained earnings: -1203803000
Receivables turnover: 28.860207100591715
Capitalized R&D asset: 84408000
ROCI (R&D-adjusted, %): -2.814511884034498
FCF margin (%): -110.33086445065226
Rule of 40 score: -110.33086445065226
Financial ratios for ABUS — annual report dated 2023-12-31
Total revenue: 18141000
Operating income: -78034000
Net income: -72849000
Capital expenditures: 988000
Operating cash flow: -85936000
Depreciation & amortization: 1404000
Net tangible assets: 106018000
Owner earnings: -72433000
Return on net tangible assets (%): -68.32141711784791
Buffett classification: The Gruesome
Stock price: 2.5
Shares outstanding: 197537710
Book value: 106018000
P/B ratio: 4.658117253673905
Market cap (USD): 493844275
Debt to equity: 0.0166764134392273
Current ratio: 5.871258949615333
Quick ratio: 5.871258949615333
Interest coverage ratio: -170.0087145969499
COGS to revenue (%): 0
R&D to revenue (%): 406.26205832093046
SG&A to revenue (%): 123.89063447439501
Free cash flow (dilution-adjusted): -96245000
Buyback yield (%): 0
Retained earnings: -1276652000
Receivables turnover: 10.214527027027026
Capitalized R&D asset: 130253360
ROCI (R&D-adjusted, %): -22.61857627674996
FCF margin (%): -530.5385590651011
Revenue growth (%): -53.50726569107358
Rule of 40 score: -584.0458247561747
Financial ratios for ABUS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.85
Shares outstanding: 197537710
Market cap (USD): 760520183.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABUS — annual report dated 2024-12-31
Total revenue: 6171000
Operating income: -69974000
Net income: -69920000
Capital expenditures: 182000
Operating cash flow: -64850000
Depreciation & amortization: 1380000
Net tangible assets: 97366000
Owner earnings: -68722000
Return on net tangible assets (%): -70.58110634102253
Buffett classification: The Gruesome
Stock price: 3.27
Shares outstanding: 197537710
Book value: 97366000
P/B ratio: 6.6342287009839165
Market cap (USD): 645948311.7
Debt to equity: 0.013238707557052769
Current ratio: 8.15187604046613
Quick ratio: 8.15187604046613
Interest coverage ratio: -510.75912408759126
COGS to revenue (%): 0
R&D to revenue (%): 875.6603467833415
SG&A to revenue (%): 358.25636039539785
Free cash flow (dilution-adjusted): -74018000
Buyback yield (%): 0
Retained earnings: -1346572000
Receivables turnover: 2.5616438356164384
Capitalized R&D asset: 131270640
ROCI (R&D-adjusted, %): -35.030775432887914
FCF margin (%): -1199.4490358126723
Revenue growth (%): -65.98313213163553
Rule of 40 score: -1265.4321679443078
Financial ratios for ABUS — quarterly report dated 2024-12-31
Capital expenditures: 86000
Buffett classification: The Gruesome
Stock price: 3.27
Shares outstanding: 197537710
Market cap (USD): 645948311.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0